Evaxion Biotech A/S (EVAX)
NASDAQ: EVAX
· Real-Time Price · USD
2.88
0.02 (0.70%)
At close: Aug 15, 2025, 3:59 PM
2.84
-1.39%
After-hours: Aug 15, 2025, 04:10 PM EDT
Evaxion Biotech A/S Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Nov 14, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | 122K | 3.03M | 153.89K | 50.88K | 73.6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | 122K | 3.03M | 153.89K | 50.88K | 73.6K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -3.87M | -4.02M | -1.74M | -4.58M | -4.39M | -4.4M | -5.76M | -5.68M | -6.39M | -6.53M | -6.08M | -6.26M | -6.4M | -7.72M | -5.91M | -7.03M | -5.17M |
Interest Income | 2.49M | n/a | 84.26K | 41K | 5.62M | 541.33K | 72K | 47K | 285K | 70K | 703K | 1.54M | 519K | 746K | 288K | 33K | 972K |
Pretax Income | -1.77M | -3.9M | -2.04M | -6.39M | 973.73K | -4.74M | -5.87M | -5.91M | -6.43M | -7.04M | -5.92M | -4.95M | -6.04M | -7.05M | -5.67M | -7.49M | -4.5M |
Net Income | -1.58M | -3.63M | -1.94M | -6.19M | 1.19M | -4.56M | -5.68M | -5.68M | -6.24M | -6.87M | -5.74M | -4.77M | -5.79M | -8.37M | -5.25M | -6.82M | -4.09M |
Selling & General & Admin | 1.71M | 1.59M | 2.13M | 1.98M | 1.61M | 2.16M | 2.93M | 2.74M | 2.54M | 2.45M | 2.02M | 2.15M | 1.59M | 1.57M | 1.5M | 1.92M | 1.28M |
Research & Development | 2.16M | 2.25M | 2.62M | 2.75M | 2.83M | 2.32M | 2.83M | 2.94M | 3.85M | 4.07M | 4.07M | 4.11M | 4.8M | 6.15M | 4.42M | 5.11M | 3.89M |
Other Expenses | n/a | 302K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 71K | n/a | n/a | n/a |
Operating Expenses | 3.87M | 4.15M | 4.76M | 4.73M | 4.44M | 4.47M | 5.76M | 5.68M | 6.39M | 6.53M | 6.08M | 6.26M | 6.4M | 7.72M | 5.91M | 7.03M | 5.17M |
Interest Expense | 397K | n/a | 385.21K | 225K | 246K | 111K | 182K | 221K | 326K | 590K | 535K | 225K | 158K | 72K | 51K | 495K | 297K |
Selling & Marketing Expenses | n/a | n/a | n/a | -1.45K | -3.75K | 292.52K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.87M | 4.15M | 4.76M | 4.73M | 4.44M | 4.47M | 5.76M | 5.68M | 6.39M | 6.53M | 6.08M | 6.26M | 6.4M | 7.72M | 5.91M | 7.03M | 5.17M |
Income Tax Expense | -192K | -275K | -96.3K | -198.85K | -217.49K | -178.45K | -194K | -225K | -194K | -173K | -175K | -177K | -247K | 1.32M | -425K | -669K | -407K |
Shares Outstanding (Basic) | 1.11M | 1.07M | 1.38M | 1.35M | 1.17M | 683.39K | 691.5K | 676.55K | 644.6K | 603.49K | 595.84K | 580.1K | 579.1K | 541.78K | 479.97K | 473.54K | 444.89K |
Shares Outstanding (Diluted) | 1.11M | 1.07M | 1.38M | 1.35M | 1.17M | 683.39K | 691.5K | 676.55K | 644.6K | 603.49K | 595.84K | 596K | 579.1K | 541.78K | 479.97K | 473.54K | 444.89K |
EPS (Basic) | -1.43 | -3.4 | -1.4 | -4.56 | 1.04 | -6.68 | -8.2 | -8.4 | -9.68 | -11.4 | -9.64 | -8.2 | -10 | -15.44 | -10.92 | -14.4 | -9.2 |
EPS (Diluted) | -2.5 | -3.4 | -1.4 | -4.56 | 1.04 | -6.68 | -8.2 | -8.4 | -9.68 | -11.4 | -9.64 | -8 | -10 | -15.44 | -10.92 | -14.4 | -9.2 |
EBITDA | -1.38M | -5.61M | -1.65M | -4.54M | 1.22M | -4.26M | -5.56M | -5.63M | -6.14M | -6.51M | -5.35M | -4.69M | -5.87M | -7.68M | -5.61M | -6.98M | -4.19M |
EBIT | -1.38M | -5.61M | -1.65M | -6.17M | 1.22M | -4.59M | -5.69M | -5.69M | -6.11M | -7.17M | -5.38M | -4.72M | -5.88M | -7.73M | -5.62M | -6.99M | -4.2M |
Depreciation & Amortization | n/a | n/a | 89.46K | 37.66K | 99.75K | 99.75K | 200K | 150K | 89.25K | 89.25K | 41.25K | 41.25K | 41.25K | 41.25K | 26.25K | 8K | 8K |